Jiabao Renhe

Beijing Jiabao Renhe Medical Technology Joint-stock Co., Ltd. (hereinafter referred to as "Jiabao Renhe"), established in 2011, is a national high-tech enterprise, a Beijing "Specialized, Refined, Distinctive, and Innovative" small and medium-sized enterprise, and an enterprise founded by talents of the "New National Gate*" talent program. It has successively won important industry awards such as the 2022 4th China Health Industry Innovation Platform In Vitro Diagnostics Innovation Qipu Award and the 2023 Liaoning Province Science and Technology Progress Award Second Prize. Jiabao Renhe focuses on the research and development and transformation of clinical-need-driven scientific research and cutting-edge technology in the maternal and child health field, committed to achieving the comprehensive integration and transformation of gene sequencing technology, bioinformatics, and big data information technology with clinical medical applications in assisted reproduction, genetics, and eugenics, the construction of reproductive genetics center laboratories, and the development and introduction of high-end laboratory equipment. Currently, it has formed an integrated service platform for reproductive health, including technology research and development, product production, testing services, testing databases, medical information network construction, and assisted reproduction genetic consumables equipment software services, providing one-stop closed-loop solutions for couples undergoing assisted reproduction, infertile patients, and people preparing for pregnancy.